Related Experiment Video
Updated: Feb 1, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Biosimilars: Are They Really Safe?
1Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago, IL, USA.
Abstract:
An increasing availability of biosimilars is an important step in the process of delivering optimal care while improving access for patients with cancer. Evolving regulatory mechanisms deal with biosimilars with different approaches within major regulatory agencies. We discuss some of the specific properties of biosimilars that merit attention in terms of optimizing their safety, delivering on appropriate related cost savings, and ensuring that appropriate premiums on innovative research are available to ensure ongoing progress in anticancer therapy.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Design Example: Calculating Safe Diameter for Wind-Exposed Disc
Conformity
Obedience
Osmoregulation in Insects

